Healing & Recovery · researchUpdated Nov 2026

BPC-157 + TB-500 Blend (Wolverine Stack) Dosage & Reconstitution Protocol

Body Protection Compound 157 + Thymosin Beta-4 Fragment Blend

A 1:1 co-lyophilized blend of BPC-157 and TB-500 sold as a single vial (5 mg/5 mg or 10 mg/10 mg). Nicknamed the 'Wolverine stack,' it pairs BPC-157's localized angiogenic and gut-protective effects with TB-500's systemic actin-regulating, cell-migration effects so one injection covers both repair pathways.

Typical Dose
500 mcg-1 mg
Frequency
Daily
Cycle Length
4–8 weeks
Administration
subcutaneous
BPC-157 + TB-500 Blend (Wolverine Stack) lyophilized reference vialBPC-157 + TB-500 Blend (Wolverine Stack) Reference Vial
Lyophilized Powder · U-100 Syringe ReferenceCalculate Draw ↓

Multi-Peptide Vial Composition

BPC-157 + TB-500 Blend (Wolverine Stack) Active Blend Ratio

BPC-157 + TB-500 Blend (Wolverine Stack) Quick Reference

Select your vial strength to update all reference concentrations, dosage tables, and syringe draws on this page.

Vial strength:
BPC-157 + TB-500 Blend (Wolverine Stack) Quick Reference (10 mg Vial)100 units = 1.0 mL · 1 unit = 0.01 mL
Vial contents
10 mg BPC-157 + TB-500 Blend (Wolverine Stack)
Final volume (Bacteriostatic Water)
2 mL (200 units)
Concentration
5 mg/mL
One U-100 syringe unit
50 mcg in 0.01 mL

Arithmetic summary: Reconstituting a 10 mg BPC-157 + TB-500 Blend (Wolverine Stack) vial with 2 mL of bacteriostatic water yields 5 mg/mL. Every 10 units (0.10 mL) on a U-100 insulin syringe delivers 500 mcg.

BPC-157 + TB-500 Blend (Wolverine Stack) 10 mg lyophilized reference vialBPC-157 + TB-500 Blend (Wolverine Stack) · 10 mg Vial

How Much To Draw

Select a row to preview the draw on the syringe. Values are reference figures from the literature, not medical advice.

10 mg Vial · 2 mL BAC Water · 50 mcg Per Unit
PhaseDosemLUnitsDoses
BeginnerOnce daily · Weeks 1–2500 mcg (250 BPC / 250 TB)0.101020
StandardOnce daily · Weeks 3–4750 mcg (375 BPC / 375 TB)0.151513
TargetOnce daily · Weeks 5–8+1 mg (500 BPC / 500 TB)0.202010
  • The 1:1 blend delivers equal BPC-157 and TB-500 per injection; TB-500 alone is usually dosed less often (2× weekly), so daily blend use front-loads TB-500 relative to a solo protocol.
  • Reconstituted vials are generally used within 28–30 days refrigerated, so supply plans allow at least one vial per 4 weeks even when a vial holds more doses.

Interactive U-100 Syringe Scale

U-100 syringe drawn to 10 units (0.10 mL), 500 mcg (250 BPC / 250 TB).

Click any dosing tier row above to preview that exact draw on the U-100 syringe scale.

How To Reconstitute BPC-157 + TB-500 Blend (Wolverine Stack)

Four steps, in order. Work on a clean surface with washed hands and swab every vial top with alcohol first.

Get Lab-Tested Vials & BAC Water at ASCND Bio →
  1. Step 1: Drawing bacteriostatic water into a sterile U-100 syringeStep 01

    Draw Bacteriostatic Water

    Draw 2 mL of bacteriostatic water (0.9% benzyl alcohol) into a sterile syringe. Use bacteriostatic, not plain sterile water, so the multi-dose vial stays preserved between draws.

  2. Step 2: Injecting bacteriostatic water slowly down the inside glass wall of the peptide vialStep 02

    Equalize & Trickle Down The Glass Wall

    Pierce the stopper and angle the needle at 45° so the water runs slowly down the inside glass wall. Never spray directly onto the lyophilized puck: the jet foams the solution and can denature fragile peptide chains.

  3. Step 3: Gently rolling the peptide vial between fingertips until completely dissolvedStep 03

    Gently Roll, Never Shake

    Roll the vial gently between your fingers or swirl in a slow circle until the liquid is 100% clear with no undissolved particles. Shaking shears peptide bonds and traps air bubbles; if it clouds, let it rest in the fridge for 15 minutes.

  4. Step 4: Storing reconstituted peptide vials upright at 2 to 8 degrees CelsiusStep 04

    Label & Store At 2–8 °C (36–46 °F)

    Write the reconstitution date and concentration on the vial. Refrigerate upright at 2–8 °C (36–46 °F), protected from light, and use within 28–30 days. Do not freeze the reconstituted liquid.

Reconstitution & Dosage CalculatorU-100 Scale (100 units = 1.0 mL · 1 unit = 0.01 mL)

BPC-157 + TB-500 Blend (Wolverine Stack) Reconstitution & Dosage Calculator

Convert a lyophilized peptide vial amount and bacteriostatic water volume into a reconstitution concentration, then translate your protocol dose and schedule into exact U-100 syringe units and multi-week vial supplies.

1Enter Vial & Water: Enter the peptide amount in your vial (mg) and bacteriostatic water volume (mL), or click Recommend Water.
2Enter Dose & Schedule: Enter your target dose in mcg or mg, pick your dosing schedule, and choose your U-100 syringe barrel.
3Follow Draw & Mixing Plan: Read the exact U-100 unit mark on the syringe, 4-step reconstitution instructions, and vials required.
1

Reconstitution

Enter the peptide amount in the vial and the volume of bacteriostatic or sterile water you plan to add.

mg
mL

Concentration

How much peptide each mL of solution contains after mixing.

5 mg/mL

Per 1 unit (0.01 mL)50 mcg
Per 10 units (0.1 mL)500 mcg
2

Your Dose & Schedule

Enter the dose from your protocol, select your dosing schedule, and pick the insulin syringe you are using.

1 mg = 1,000 mcg
Insulin syringe (U-100)

100-unit (1 mL): marks every 2 units. Standard barrel for draws up to 100 units.

Your Draw & Reconstitution Plan

✓ Aligns cleanly on graduation mark

Draw to

5units

Pull plunger seal to line 5

Volume

0.05 mL

Delivers 250 mcg

Doses per vial

20

Lasts 20 days (Once daily)

4-Week Schedule Supply

2 vials

28 doses · 2.0 mL BAC water

To-Scale U-100 Insulin Syringe (100-Unit / 1.0 mL Barrel)Read volume at the leading edge of the black plunger seal facing the needle
10 units

How to Reconstitute for Your Dosage Schedule

Once Daily
  1. 1Equilibrate & Sanitize: Remove your 5 mg vial from freezer storage and allow it to equilibrate at room temperature for 15–20 minutes. Swab both stoppers with 70% isopropyl alcohol.
  2. 2Draw & Inject Diluent Down Wall: Draw 1.0 mL (100 units) of bacteriostatic water and inject slowly down the inside glass wall at a 45° angle to prevent foaming.
  3. 3Swirl Gently & Refrigerate: Gently swirl or roll until dissolved (do not shake). Your concentration is 5 mg/mL (50 mcg/unit). Label and refrigerate at 2–8 °C.
  4. 4Draw Your Scheduled Dose: For each 250 mcg injection, pull the plunger to 5 units (0.05 mL) on your U-100 syringe.

Supplies Needed by Schedule Duration

5 mg vial · 250 mcg/dose
DurationTotal PeptideVials RequiredU-100 SyringesBAC Water

For educational and research calculations only. Always confirm calculations independently before use.

Supplies Needed for BPC-157 + TB-500 Blend (Wolverine Stack)

Plan vials, U-100 insulin syringes, bacteriostatic water, and sterile alcohol prep pads by protocol duration.

Bacteriostatic water, lyophilized peptide vial, U-100 insulin syringes, and sterile alcohol prep pads
4 Core Supplies: 10 mg BPC-157 + TB-500 Blend (Wolverine Stack) vials, Bacteriostatic Water (0.9% benzyl alcohol), U-100 insulin syringes, and 70% isopropyl alcohol pads.

1-, 2-, and 4-Week Supply Reference (10 mg Vial Format)

750 mcg (375 BPC / 375 TB) · Once daily

BPC-157 + TB-500 Blend (Wolverine Stack) Vials (10 mg each):

  • 1 week (5.3 mg total):1 vial required
  • 2 weeks (10.5 mg total):2 vials required
  • 4 weeks (21 mg total):3 vials required

U-100 Insulin Syringes & Alcohol Pads:

  • 1 week:7 syringes · 14 pads
  • 2 weeks:14 syringes · 28 pads
  • 4 weeks:28 syringes · 56 pads

8 Weeks

10 mg Vial
VialsBPC-157 + TB-500 Blend (Wolverine Stack) mg vials
6
U-100 Syringesone sterile syringe per dose
62
BAC Water30 mL multi-dose vials
2
Alcohol Padsvial stopper + skin prep
118

56 total doses over 8 weeks

12 Weeks

10 mg Vial
VialsBPC-157 + TB-500 Blend (Wolverine Stack) mg vials
9
U-100 Syringesone sterile syringe per dose
93
BAC Water30 mL multi-dose vials
2
Alcohol Padsvial stopper + skin prep
177

84 total doses over 12 weeks

16 Weeks

10 mg Vial
VialsBPC-157 + TB-500 Blend (Wolverine Stack) mg vials
12
U-100 Syringesone sterile syringe per dose
124
BAC Water30 mL multi-dose vials
3
Alcohol Padsvial stopper + skin prep
236

112 total doses over 16 weeks

Synergistic Protocols

Popular BPC-157 + TB-500 Blend (Wolverine Stack) Stacks & Co-Administration

Common research and clinical combinations pairing BPC-157 + TB-500 Blend (Wolverine Stack) with complementary pathways.

Gold-Standard Tissue & Tendon RepairCycle: 6–12 weeks on · 2–4 weeks off

The Wolverine Stack (BPC-157 + TB-500)

Accelerates tendon, ligament, muscle, and joint recovery by pairing localized angiogenesis (BPC-157) with systemic actin upregulation (TB-500).

CompoundProtocol DoseTiming & Route
BPC-157250–500 mcg daily (10–20 U on 5mg/2mL)Once or split AM/PM SubQ
TB-500 (Thymosin Beta-4)2.0–2.5 mg twice weekly (or 350–500 mcg daily)SubQ abdominal or near injury

Stacking Note: Can be drawn into the same insulin syringe immediately prior to injection or purchased as a pre-mixed 10mg/10mg blend vial.

70 mg 3-Compound Collagen & Regeneration BlendCycle: 6–8 weeks on · 4 weeks off

The GLOW Protocol (GHK-Cu + BPC-157 + TB-500)

Combines high-dose copper peptide (50 mg GHK-Cu) with 10 mg BPC-157 and 10 mg TB-500 to remodel collagen, elastin, skin density, and connective tissue while minimizing copper injection sting.

CompoundProtocol DoseTiming & Route
GHK-Cu (Copper Peptide)1.75–2.5 mg per daily drawOnce daily SubQ (3 mL BAC in 70 mg vial)
BPC-157350–500 mcg per daily drawCo-administered in blend
TB-500350–500 mcg per daily drawCo-administered in blend

Stacking Note: Standard 70 mg GLOW vial reconstituted with 3.0 mL BAC water: drawing 7–10 units delivers ~1.6–2.3 mg GHK-Cu + 330–460 mcg each of BPC-157 and TB-500.

80 mg 4-Compound Anti-Inflammatory & Gut/Skin StackCycle: 8 weeks on · 4 weeks off

The KLOW Protocol (GHK-Cu + BPC-157 + TB-500 + KPV)

Adds 10 mg KPV (alpha-MSH tripeptide) to the GLOW formula to downregulate NF-kB/TNF-alpha systemic and gastrointestinal inflammation.

CompoundProtocol DoseTiming & Route
GHK-Cu + BPC-157 + TB-50050 mg / 10 mg / 10 mg baseOnce daily SubQ (3 mL BAC in 80 mg vial)
KPV Tripeptide350–500 mcg per daily drawCo-administered in 80 mg KLOW vial

Stacking Note: Ideal for protocols targeting simultaneous gut mucosal repair, autoimmune calm, and dermal/tendon remodeling.

Subcutaneous Injection Sites & Storage

Rotate sites with every injection so no single area is used twice in a row. Swab with alcohol and let it dry for 10 seconds before injecting.

3D anatomical map showing abdomen (2 inches from navel), outer anterior thigh, and upper arm subcutaneous injection zones

Zone 01

Abdomen

≥ 2 in away from navel

Zone 02

Outer Thigh

Middle third, anterior-lateral

Zone 03

Upper Arm

Posterior / outer tricep pad

Pinch & Needle Angle

90° · 4–8 mm (31 G) short needle

Standard U-100 insulin syringe: pinch a light fold and insert straight in at 90°.

45° · 12.7 mm (1/2 in) needle

Longer needle or leaner area: pinch a 1-inch fold and enter at 45° into fat.

Aseptic Injection Checklist

• Use a brand-new sterile U-100 syringe for every draw (never reuse needles).

• Swab both the vial rubber stopper and injection site with 70% isopropyl alcohol and let dry.

• Rotate clockwise around the abdomen or alternate left/right thigh to prevent lipohypertrophy.

Lyophilized Powder (Unmixed)

Freezer −20 °C Long-Term · Fridge Short-Term

Unmixed freeze-dried vials stay stable for months in the refrigerator and 1–2+ years at −20 °C (0 °F) in the dark. Let the vial warm to room temperature before opening.

Reconstituted Liquid (Mixed)

Refrigerate 2–8 °C (36–46 °F) · Use Within 30 Days

Keep refrigerated and out of light once mixed with bacteriostatic water. Never freeze reconstituted liquid — ice crystals shear the dissolved peptide chains.

Pharmacology & Evidence

Mechanism & Clinical Research

How It Works

BPC-157 promotes angiogenesis via VEGFR2 and the FAK-paxillin pathway and modulates nitric oxide signaling at the injury site, while TB-500 (thymosin beta-4 active fragment) sequesters G-actin to drive cell migration, reduces inflammatory cytokines, and promotes new blood vessel formation systemically. Combining the two targets local tissue remodeling and whole-body recovery in the same dose.

Common Dosing References

subcutaneous

500mcg-1mg · Daily

4-8 weeks

subcutaneous (maintenance)

500mcg · 3-5x weekly

Ongoing as needed

Research use only. Not medical advice.

What The Research Shows

  1. 2019

    Thymosin beta-4 and BPC-157 in wound healing models

    Independent animal studies show each peptide accelerates tendon, muscle, and skin healing; combination data in humans remains anecdotal

  2. 2012

    Thymosin beta-4 promotes angiogenesis and cell migration

    Tβ4 increased endothelial cell migration and vessel sprouting in vitro and in rodent models

Regulatory Status

Research compound; not FDA-approved. Neither component is approved for human use in the United States, and BPC-157 is on the FDA Category 2 bulk-substance list restricting compounding.

Clinical Profile

Potential Benefits

  • Single-vial convenience for the most common healing stack
  • Accelerated tendon and ligament repair
  • Faster recovery from muscle strains and training load
  • Reduced localized and systemic inflammation
  • Supports gut lining repair (BPC-157 component)
  • Improved flexibility and range of motion (TB-500 component)

Reported Side Effects

  • Injection site redness or irritation
  • Transient fatigue or lethargy (TB-500 component)
  • Headache
  • Nausea (rare)
  • Mild dizziness or head rush after injection

Provider Directory

Confirmed Clinics & Sourcing

Sourcing Notes

Sold by research peptide vendors as a pre-mixed lyophilized vial. Confirm the COA lists BOTH peptides at the stated mass; some vendors label the combined mass (10 mg) without specifying the ratio.

Free Guide

Get BPC-157 + TB-500 Blend (Wolverine Stack) research updates

New studies, regulatory changes and sourcing notes on the peptides you follow. One email a week, no spam.

Free. No spam. Unsubscribe anytime. From GLP1Search.

Find peptide-aware clinics

Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.

Search Local Clinics